Billionaire George Soros is Selling These 5 Stocks in 2022

3. UnitedHealth Group Incorporated (NYSE:UNH)

Number of Hedge Fund Holders: 96

UnitedHealth Group Incorporated (NYSE:UNH) is a diversified health care company in the United States, offering managed healthcare, pharmacy benefits, and insurance services. George Soros’ fund held 19,818 shares of UnitedHealth Group Incorporated (NYSE:UNH) in Q4 2021, worth about $10 million. Soros Fund Management disposed of its stake in the first fiscal quarter of 2022. 

On April 19, BMO Capital analyst Matt Borsch lifted the price target on UnitedHealth Group Incorporated (NYSE:UNH) to $600 from $510 and reiterated a Market Perform rating on the shares. The analyst cited UnitedHealth Group Incorporated (NYSE:UNH)’s “solid” Q1 results with robust Medicare Advantage penetration and the expansion of its value-based care initiative. He added that UnitedHealth Group Incorporated (NYSE:UNH) remains well positioned as healthcare outpaces GDP growth and managed care overrides government Medicare and Medicaid programs.

In Q4 2021, 96 hedge funds were bullish on UnitedHealth Group Incorporated (NYSE:UNH), with collective stakes worth $13.6 billion, compared to 95 funds in the earlier quarter, holding stakes in the company valued at $11.7 billion. Boykin Curry’s Eagle Capital Management held a leading position in UnitedHealth Group Incorporated (NYSE:UNH) in the first fiscal quarter of 2022, with 2.90 million shares worth $1.48 billion. 

Here is what Baron Durable Advantage Fund has to say about UnitedHealth Group Incorporated (NYSE:UNH) in its Q1 2022 investor letter:

“UnitedHealth Group Incorporated (NYSE:UNH) is a leading diversified health and wellbeing company whose divisions include insurance arm, United Healthcare and healthcare services arm, Optum, which offers care delivery and other services. Shares increased 1.8% on good fourth quarter results with revenues up 12.5% year-over-year, operating margins of 7.5% and EPS up 78% while also reaffirming its 2022 guidance. We believe UnitedHealth leads the healthcare industry in innovation and execution as evidenced by its strong value proposition leading to Medicare Advantage share gains, strong cost controls, and its leadership position in the shift to value-based care.”